BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 10879223)

  • 1. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
    Hasnan J; Jayaram G
    Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of silver binding nucleolar organiser regions (AgNORs) of breast lesions in histological sections and fine needle aspiration smears.
    Basu A; Sanyal S; Bhattacharyya A; Bhattacharyya S; Dasgupta S
    J Indian Med Assoc; 1997 Aug; 95(8):443-7. PubMed ID: 9492450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of AgNORS in fine needle aspiration cytology of breast lesions.
    Rajeevan K; Aravindan KP; Kumari BC
    Indian J Pathol Microbiol; 1995 Jan; 38(1):17-24. PubMed ID: 8919465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolar organizer regions in human breast cancer.
    Roller E; Fritz P; Wicherek C; Klumpp B; Lauinger J; Mischlinski A; Wanner B; Schumacher K
    Zentralbl Pathol; 1993 Aug; 139(3):195-9. PubMed ID: 8218120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic relevance of silver stained nucleolar organizer region (AgNORs) in benign and malignant breast lesions.
    Agarwal PK; Mehrotra A; Chandra T
    Indian J Exp Biol; 1995 Oct; 33(10):715-20. PubMed ID: 8575800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
    Dube MK; Govil A
    Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cytological morphologic criteria and AgNOR expression in male breast lesions.
    Karakitsos P; Botsoli-Stergiou EM; Ioakim-Liossi A; Georgoulakis J; Markopoulos C; Gogas J; Kyrkou K
    Cytopathology; 1998 Apr; 9(2):107-13. PubMed ID: 9577737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolar organizer regions in breast cytology material.
    Rath-Wolfson L; Hamel I; Halpern M; Klein B; Gal R
    Acta Cytol; 1995; 39(5):852-7. PubMed ID: 7571959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of the "gray zone" in breast cytology. A review of 186 cases of atypical and suspicious cytology.
    al-Kaisi N
    Acta Cytol; 1994; 38(6):898-908. PubMed ID: 7992576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical significance of AgNOR counts in FNAC smears and corresponding histopathological sections.
    Mehrotra A; Chandra T
    Indian J Exp Biol; 1998 Feb; 36(2):162-6. PubMed ID: 9754045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements.
    Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L
    Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fine needle aspiration cytology and excisional biopsy in palpable breast cancers.
    Müslümanoğlu M; Dolay K; Ozmen V; Iğci A; Bozfakioğlu Y
    Radiol Med; 1995 Mar; 89(3):225-8. PubMed ID: 7754112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of fixation and preparation on the AgNOR distribution in routinely processed breast cancer specimens.
    Biesterfeld S; Ruoss E; Hufnagl P; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):41-8. PubMed ID: 7515672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silver-binding nucleoli and nucleolar organizer regions in fine needle aspiration cytology of the breast.
    Giri DD; Dundas SA; Sanderson PR; Howat AJ
    Acta Cytol; 1989; 33(2):173-5. PubMed ID: 2929216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized in situ AgNOR analysis in breast pathology: diagnostic and cell kinetic implications.
    Bànkfalvi A; Ofner D; Schmid KW; Schmitz KJ; Breukelmann D; Krech R; Böcker W
    Pathol Res Pract; 1999; 195(4):219-29. PubMed ID: 10337659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AgNOR, Ki-67 and PCNA expression in fibroepithelial tumours of the breast in correlation with morphological features.
    Barwijuk-Machała M; Musiatowicz B; Cylwik J; Reszeć J; Augustynowicz A
    Folia Morphol (Warsz); 2004 Feb; 63(1):133-5. PubMed ID: 15039920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of liquid-based cytology in the investigation of breast lesions using fine-needle aspiration: a cytohistopathological evaluation.
    Kontzoglou K; Moulakakis KG; Konofaos P; Kyriazi M; Kyroudes A; Karakitsos P
    J Surg Oncol; 2005 Feb; 89(2):75-8. PubMed ID: 15660372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [AgNOR in the pathologic differential diagnosis of tumors].
    Chen BF
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):463-6. PubMed ID: 1315672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolar organizer regions as discriminators for the diagnosis of well-differentiated adenocarcinoma of the prostate.
    Schned AR
    Arch Pathol Lab Med; 1993 Oct; 117(10):1000-4. PubMed ID: 8215819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.